A Growing Competitive Pipeline of Innovative Drug Candidates in Various Disease Areas

AbVision has built a differentiated, competitive pipeline for antibody therapy, vaccine and cell therapy at various developmental stages. Our therapeutic antibody program centers as a best or first-in-class antibody targeting a variety of cancers. The next generation of vaccine is able to elicit a strong and long lasting of immune response by trace amount of immunogens without repeated immunization. The cell therapy products successfully overcome the major obstacles of cell therapy on ex vivo expansion and tumor recognition.